ARCHIVES

Tykerb And Trastuzumab Showed Increase In PFS For HER2+ Breast Cancer In Study

This article is from The Cancer Letter archive.

Vol. 31 No. 5 | May 30, 2008

Download PDF Visit The Full Archive

Related Articles

ASCO: NCI Authorities Still Important

June 11, 2010

Study Shows MammaPrint Test Can Predict 25-Year Risk Levels

February 28, 2014

CALGB Chairman Schilsky To Step Down After 15 Years Leading Cooperative Group.

February 1, 2008

Benefit Of Chemotherapy Depends ER Status

April 28, 2006

Phase IIb Trial of Vintafolide-Docetaxel Combination Meets Primary Endpoint of Progression-Free Survival

March 28, 2014

DCE Board Sets Aside $2 Million For Radiation Grants Program; Okays Concept For Add-On To ASCUS Trial

October 13, 1995